Comparison

Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide European Partner

Item no. HY-153892-1mg
Manufacturer MedChem Express
CASRN 2750623-07-3
Amount 1 mg
Quantity options 10 mg 1 mg 5 mg
Category
Type Amino Acid Derivates
Specific against other
Purity 99.79
Dry ice Yes
Citations [1]Zhu Yi, et al. Camptothecin derivative and ligand-drug conjugate thereof. WO2022078260A1. 2021.
Smiles OC(CNC[C@H](N1C(C=CC1=O)=O)C(NCC(NCC(N[C@@H](CC2=CC=CC=C2)C(NCC(NCO[C@@H](C)C(N[C@@H]3C4=C5C(C(N6C5)=CC([C@](O)(C(OC7)=O)CC)=C7C6=O)=NC8=CC(F)=C(C)C(CC3)=C84)=O)=O)=O)=O)=O)=O)=O
Shipping Condition Dry ice
Available
Manufacturer - Type
ADC Related
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
Drug-Linker Conjugates for ADC; Topoisomerase
Shipping Temperature
Dry Ice
Storage Conditions
-80°C, protect from light
Molecular Weight
1079.05
Product Description
Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide is the drug-linker conjugate for ADC, containing ADC linker Gly-Mal-GGFG and ADC cytotoxin Deruxtecan 2-hydroxypropanamide[1].
Manufacturer - Research Area
Cancer
Solubility
10 mM in DMSO
Manufacturer - Pathway
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close